Video & Transcript Research : 'disease testing'
Page 18 of 453
TX
Texas 89th Regular
89th Legislative Session - Second Called Session Sep 3rd, 2025
Texas House Floor Meeting
Bills:
SB 1, HCR 20, HR 131, HR 133, HR 135, HR 136, HR 137, HR 144, HR 145, HR 146, HR 149, HR 150, HR 151, HR 152, HR 158, HR 161, HR 162, HR 163, HR 165, HR 166, HR 168, HR 169, HR 170, HR 175, HR 178, HR 127, HR 129, HR 130, HR 132, HR 134, HR 138, HR 139, HR 140, HR 141, HR 142, HR 143, HR 153, HR 154, HR 155, HR 156, HR 159, HR 160, HR 164, HR 167, HR 172, HR 173, HR 176, SB 1, HB 8, HB 15, HB 27, SB 5
Keywords:
campground safety, youth camp regulations, flood safety, emergency evacuation, health and safety standards, memorial, remembrance, legacy, condolences, community, higher education, university merger, research, public health, economic impact, healthcare, insurance, affordability, medical coverage, state regulations
HI
Bills:
HB1800, HB2095, HB1158, HB1518, HB1752, SCR23, SCR24, SCR25, SCR26, SCR27, SCR28, SCR29, SCR30, SCR31, SCR32, SCR33, SCR34, SCR35, SCR36, SCR37, SCR38, SCR39, SCR40, SCR41, SCR42, SCR43, SCR44, SCR45, SCR46, SCR47, SCR48, SCR49, SCR50, SCR51, SCR52, SCR53, SCR54, SCR55, SCR56, SCR57, SCR58, SCR59, SCR60, SCR61, SCR62, SCR63, SCR64, SCR65, SCR66, SCR67, SCR68, SCR69, SCR70, SCR71, SCR72, SCR73, SCR74, SCR75, SCR76, SCR77, SCR78, SCR79, SCR80, SCR81, SCR82, SCR83, SCR84, SCR85, SCR86, SCR87, SCR88, SCR89, SCR90, SCR91, SCR92, SCR93, SCR94, SCR95, SCR96, SCR97, SCR98, SCR99, SCR100, SCR101, SCR102, SCR103, SCR104, SCR105, SCR106, SCR107, SCR108, SCR109, SCR110, SCR111, SCR112, SCR113, SCR114, SCR115, SCR116, SCR117, SCR118, SCR119, SCR120, SCR121, SCR122
Keywords:
supplemental appropriations, state budget, Hawaii budget, biennial budget, capital improvement projects, CIP, general fund, special fund, green fee, special land and development fund, clean energy revolving loan fund, agricultural development revolving fund, community grants, nonprofit grants, Office of Community Services, housing, affordable housing, homelessness, health care, mental health
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 29th, 2026 at 01:30 pm
Oklahoma Senate Floor Meeting
Bills:
HB2268, HB3000, HB3043, HB3066, HB3078, HB3143, HB3144, HB3244, HB3298, HB3320, HB3467, HB3321, HB3329, HB3431, HB3464, HB3499, HB3500, HB3586, HB3590, HB3650, HB3671, HB3695, HB3700, HB3701, HB3764, HB3767, HB3834, HB3931, HB3934, HB3940, HB3944, HB3979, HB3985, HB4113, HB4294, HB4302, HB4317, HB4324, HB4359, HB4426, HB4427, HB4430, HB4431, HB4434, HJR1077, SR42, SR35, HJR1023, HB1225, HB1374, HB1381, HB1590, HB1675, HB2153
Keywords:
HB2268, Oklahoma Health Care Authority, OHCA, appropriation, General Revenue Fund, PACE, Programs of All-Inclusive Care for the Elderly, elderly care, aging Oklahomans, long-term care, Medicaid, health care funding, provider reimbursement, rate increase, low-income seniors, senior services, integrated care, emergency measure, cosmetology, barbering
OK
Oklahoma 2026 Regular Session
Senate Legislative Session Apr 29th, 2026 at 09:00 am
Oklahoma Senate Floor Meeting
Bills:
HB2268, HB3000, HB3043, HB3066, HB3078, HB3143, HB3144, HB3244, HB3298, HB3320, HB3467, HB3321, HB3329, HB3431, HB3464, HB3499, HB3500, HB3586, HB3590, HB3650, HB3671, HB3695, HB3700, HB3701, HB3764, HB3767, HB3834, HB3931, HB3934, HB3940, HB3944, HB3979, HB3985, HB4113, HB4294, HB4302, HB4317, HB4324, HB4359, HB4426, HB4427, HB4430, HB4431, HB4434, HJR1077, SR42, SR35, HJR1023, HB1225, HB1374, HB1381, HB1590, HB1675, HB2153
Keywords:
HB2268, Oklahoma Health Care Authority, OHCA, appropriation, General Revenue Fund, PACE, Programs of All-Inclusive Care for the Elderly, elderly care, aging Oklahomans, long-term care, Medicaid, health care funding, provider reimbursement, rate increase, low-income seniors, senior services, integrated care, emergency measure, cosmetology, barbering
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Public Health Jun 21st, 2026 at 10:00 am
Joint Committee on Public Health
Transcript Highlights:
- the disease remain undiagnosed.
- But celiac disease doesn't wait.
- But no one ever tested me for celiac disease.
- She tested me for celiac disease, a disease that often gets overlooked.
- She tested me for celiac disease, a disease that often gets overlooked, especially when classic GI symptoms
Summary:
The Joint Committee on Public Health heard testimony on four bills: H. 5013 and S. 2928, which would establish a three-year celiac disease screening pilot program for children during routine cholesterol/lipid screening at ages 8 to 12; H. 5087, regulating medical spas; and H. 5115, establishing statewide food truck regulations, though the transcript focused almost entirely on the celiac and medical spa bills. For the celiac proposal, Rep. Badger and Sen. Lovely described long diagnostic delays, the lack of a cure, and the potential for a simple blood test to identify children earlier and reduce long-term harm. Multiple patients, clinicians, and researchers supported the pilot, saying celiac is frequently missed because symptoms vary widely or are absent, and that early detection could prevent malnutrition, growth problems, osteoporosis, and other complications. Testifiers also emphasized that the bill would study feasibility, accuracy, cost, and acceptability, and would include family education and support resources if diagnoses are made through the program.
Several experts and advocates backed the celiac screening pilot, including a pediatric gastroenterologist from Italy who described successful national screening efforts there, a Celiac Disease Foundation representative, pediatric gastroenterologists from Massachusetts and Colorado, a pediatric dietitian, and a parent whose child was diagnosed after severe malnutrition. They argued that routine screening alongside existing pediatric bloodwork could identify many undiagnosed children and improve health equity, since celiac disease is often overlooked in people of color and lower-income patients. Committee members asked about how the screening would work, and witnesses explained it could begin with a blood test, followed by confirmatory endoscopy if needed. No vote was taken in the hearing.
On H. 5087, witnesses from the medical aesthetics industry largely opposed the bill as written, saying it was outdated, redundant with existing Massachusetts licensing and board oversight, and too restrictive for nurse practitioners, physician assistants, and other licensed providers. Testifiers, including a retired lobbyist, a nurse practitioner, a PA, a plastic surgeon, and a clinic owner, said the bill could reduce access, raise costs, and push care into less regulated settings, while not addressing the real issues of training, compliance, and patient safety. Committee members pressed for more specific feedback on what provisions were unnecessary or duplicative, and witnesses said they had submitted position papers and written testimony identifying conflicts with current law. The hearing ended with the chair noting that all oral and written testimony would be reviewed before any decisions are made.
LA
Louisiana 2026 Regular Session
Chronic Wasting Disease TF Jan 7th, 2026
Transcript Highlights:
- We do ELISA testing.
- disease or EHD.
- And multiple tests positive for chronic wasting disease, including in her brain.
- And we've learned a lot about chronic wasting disease on the backs of these two tests.
- We could test soil. We could test rocks. We could kind of do anything.
Summary:
The meeting began with roll call, adoption of the agenda, and approval of the prior minutes. The main presentation was from Julie Grenwald of Louisiana Hunters for the Hungry, who described the nonprofit’s protein donation programs, including freezer clean-out days, deer and fish processing partnerships, and a paused feral hog donation program that had collected about 3,500 hogs and 137,000 pounds of pork before funding ran short. She said the group has donated roughly 300,000 pounds of protein over two years, works with food banks and local agencies, and is protected under Louisiana’s Good Samaritan Law. Members asked about processor locations, exotic species, signage, sponsorships, and whether the program could expand to other invasive species or mobile drop-off options; Grenwald said expansion is possible if processors and funding are available.
The task force then received a Louisiana Department of Wildlife and Fisheries update from Jonathan Bordelon on chronic wasting disease testing. He reported more than 2,800 samples collected and over 2,300 results returned, with nine positives total: eight in Tensas Parish and one confirmed in Concordia Parish on Richard K. Yancey WMA, which triggered preparation of an emergency declaration and future rulemaking to adjust the control area. He said harvest and sampling remain near record levels, most samples are voluntary, and the agency continues to monitor symptomatic deer reports and public submissions.
The final major presentation was from William McKinley of the Mississippi Department of Wildlife, Fisheries and Parks, who gave a detailed overview of Mississippi’s CWD response. He said Mississippi has 529 detections across 18 counties, with prevalence rising from about one in 500 samples to about one in 80 statewide, and much higher in some counties. He described Mississippi’s surveillance system, targeted tags within three miles of positives, environmental sampling, feeder bans in CWD zones, and research showing contamination at feeders and in scrapes. He also discussed possible multiple strains, including one linked to the Wisconsin whitetail strain and another around Vicksburg/Issaquena, and said the disease appears to be expanding about 3.5 miles per year. Members asked about high-fence enclosures, live deer movement restrictions, baiting and feeding rules, hunter participation, and whether Louisiana should develop similar environmental testing capacity; no votes were taken on these issues, but members discussed possible future legislative or budget action.
TX
Texas 89th 2nd C.S.
Appropriations - S/C on Articles VI, VII, & VIII Feb 27th, 2025
Appropriations - S/C on Articles VI, VII, & VIII
Transcript Highlights:
- By that date, 797 cervids had tested positive for chronic wasting disease in Texas total since 2012.
- By that date, 797 servants had tested positive for chronic 393 wasting disease in Texas total since 2012
- Uh, we do not have a good antemortem test, uh, where in some other disease programs like brucellosis
- The definitive test in CWD is a postmortem test, where you have to take the brain stem out to test.
- test.
Summary:
The committee met with a quorum present to hear Article VI Natural Resources agency budget recommendations, beginning with the Railroad Commission. LBB staff summarized the commission’s 2026-27 base recommendation at $458.7 million, down from the prior biennium, with an increased FTE cap. The presentation highlighted reduced federal IIJA funding, volatility in oil and gas regulation account 5155, continued support for IT modernization, and rider changes. The commission’s major exceptional items were then presented, including requests for produced water and injection data reporting, an authorized pit registration system, regulatory filing/permitting upgrades, an underground injection well investigation team, site remediation support, and especially $100 million for orphan well plugging. Members asked about biennium-to-biennium comparisons, salary biennialization, the scale of orphan well risks, federal funding delays, bonding, and whether the state should rely more on industry or general revenue for plugging costs. Commission leadership explained that orphan wells can threaten water and public safety, that plugging costs have risen sharply, and that current funding is insufficient to keep up with emergency wells and the backlog; they also said the agency is moving to cloud-based systems with cybersecurity protections and that the proposed performance measure may need adjustment if funding does not increase.
The Railroad Commission testimony was followed by LBB and agency testimony for the Texas Animal Health Commission. LBB described a $42 million recommendation for 2026-27, an increase overall, but with a reduced FTE cap due to turnover and salary reallocation. The recommendation maintained funding for cattle fever tick work, chronic wasting disease, lab testing through an MOU with Texas A&M’s veterinary diagnostic lab, and a new $5 million spay-and-neuter pilot program, while deleting a capital budget rider and adjusting riders tied to entry point inspection stations and clinical trials. Agency leadership then outlined the commission’s mission to protect livestock health and the state’s $22 billion animal industry, and described major disease threats including highly pathogenic avian influenza, cattle fever ticks, New World screwworm, and chronic wasting disease. Their exceptional items focused on recruiting and retaining veterinarians, replacing fleet vehicles, creating an ectoparasite identification lab, adding field staff and IT support, improving records and epidemiology reporting, strengthening central administration, supporting secure food supply planning, expanding chronic wasting disease work, and staffing the new spay-and-neuter program. Members asked about field identification of ticks, the use of disinfectants and PPE, fleet management, the scale of cattle fever tick risk, and chronic wasting disease; the agency explained its current inspection and lab-confirmation process, its reliance on field disinfecting and biosecurity, and the need for more staff and better data systems to keep pace with growing workloads and disease threats.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Public Health Jun 21st, 2026 at 01:00 pm
Joint Committee on Public Health
Transcript Highlights:
- He called genetics to run one more test, a simple blood test.
- FDA approved treatments for GOSHA disease. The test is already being done in Massachusetts.
- I'm just asking you to add Fabry disease and Gaucher disease and NPS1 and Pompe disease and the rest
- I also run a Fabry disease clinic, and I am a person living with Fabry disease.
- disease.
Summary:
The Joint Committee on Public Health heard testimony on a wide range of bills focused on children’s health, tobacco control, newborn screening, pediatric cancer, palliative care, and professional licensure. Early testimony highlighted Senate bills to expand newborn screening for pyruvate dehydrogenase complex deficiency, lysosomal storage disorders, and congenital CMV, with families and clinicians describing severe diagnostic delays, missed treatment windows, and the benefits of early detection. Speakers also supported a bill to improve pediatric cancer research through a dedicated trust fund, and a bill to extend pediatric palliative care services to age 22, with parents and providers emphasizing continuity of care for seriously ill young people.
Several witnesses gave personal accounts in support of the newborn screening measures. Families described children who endured years of misdiagnosis before receiving diagnoses such as Gaucher disease, Fabry disease, Pompe disease, Niemann-Pick disease, and CMV, often after irreversible damage had already occurred. Medical and advocacy witnesses said Massachusetts already collects some of the relevant screening data and argued that results should be reported to families, while others urged the committee to add conditions to the state panel because effective treatments already exist. The committee also heard support for a bill to establish a fetal alcohol spectrum disorder program and training for providers.
On tobacco and youth health, testimony supported bills to ban internet tobacco sales, strengthen youth protections, and reduce lung cancer deaths through point-of-sale information and quit-line access. A student testified about easily purchasing flavored nicotine products online without meaningful age verification, and public health advocates backed measures to keep tobacco out of children’s environments. The committee also heard testimony on a bill to ensure parents have access to their children’s medical records through age 16, with exceptions for sensitive services already protected by law.
The committee additionally took testimony on an optometry licensure bill, where ophthalmologists opposed language they said could broaden scope of practice and allow optometrists to use the title “optometric physician,” while optometry educators and students supported the bill as a modernization measure with no scope expansion. No votes were taken during the hearing; the chair repeatedly reminded speakers of time limits and noted that written testimony could be submitted for additional comments.
AR
Arkansas 2026 1st Special Session
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL Jul 9th, 2026
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL
Transcript Highlights:
- We to detect this disease earlier and less expensive.
- It's a very exciting time to work on this disease.
- POINTER tested for us is we tested two cohorts of people. One was in a guided group.
- disease.
- Because as the disease progresses, the needs of the families change.
Summary:
The Arkansas Alzheimer’s Disease and Dementia Advisory Council met to introduce members, adopt its rules and procedures, approve prior minutes, and authorize the co-chairs to approve special expenses. The main discussion focused on updating the Arkansas State Plan for Alzheimer’s disease and dementia, with David Cook of the Alzheimer’s Association outlining major changes in prevalence, caregiving burden, diagnostics, and treatment since the prior plan. He noted rising disease and caregiver numbers in Arkansas, the expansion of amyloid PET access, the growing use of blood-based biomarkers, and the availability of FDA-approved treatments such as Leqembi and Kisunla, while emphasizing that access, insurance coverage, and provider education remain major barriers.
Members and presenters also discussed the need to better reach rural primary care providers, who may not be aware of new diagnostics and therapies, and the bottlenecks caused by limited specialists and infusion capacity. There was concern about overreliance on blood tests without confirmatory evaluation, and several members stressed the importance of collaboration, public education, and promoting brain health through exercise and diet. The council also heard about existing programs such as the dementia services coordinator, the BOLD grant, caregiver respite grants, workforce training, and a pilot dementia resource center with UAMS Centers on Aging.
The council approved a new four-part outline for the next state plan: advancing risk reduction and brain health/early detection, strengthening family caregiver support, improving access to diagnostics and treatment, and supporting access and quality of care, including workforce and crisis response. Members also agreed to consider future agenda items on new treatments, brain health and lifestyle prevention, workforce training, and possible legislative changes to the enabling statute. The meeting ended with discussion of scheduling the next meeting, tentatively set for August 12 in Hot Springs, and adjournment.
MN
Minnesota 2025-2026 Regular Session
House Agriculture Finance and Policy Committee 2/26/25
Agriculture Finance and Policy
Transcript Highlights:
- , free testing, confidential testing.
- , free testing, confidential testing.
- , free testing, confidential testing.
- Give them options for testing, free testing, confidential testing. Um, uh, confidential testing.
- Give them options for testing, free testing, confidential testing. Um, uh, confidential testing.
Keywords:
agriculture, depredation compensation, livestock, crop damage, elk, wolves, wildlife management, skills path program, career and technical education, CTE, dual credit, postsecondary options enrollment, apprenticeship, apprenticeship readiness, dual training, work-based learning, career pathways, skilled trades, workforce development, high school to career
AL
Transcript Highlights:
- So, once they’re tested and if the disease is found, then who owns the right or has the first right of
- He just didn't have a way to test for it and didn't know to. way to test for it and didn't know to test
- But everywhere they've tested between 0.5 and 1% test tested between 0.5 and 1% test positive.
- Eight of them tested killed 100 deer. Eight of them tested positive. About 0.7% tested positive.
- The threat of this disease, such as chronic wasting disease, such as chronic wasting disease pose a very
NH
New Hampshire 2025 Regular Session
House Finance Division III (03/04/2025)
Transcript Highlights:
- So now we are getting to our laboratory that conducts laboratory testing for disease prevention and control
- c> control Testing for disease prevention control Testing for disease prevention control and<03:20
- For our P, um, testing, and this does testing for PAS testing in drinking water for homeowners and for
- tested Ed shellfish um we've tested tested Ed shellfish um we've tested water<03:25:49.239>
samples - number of tests that we the covid tests number of tests that we the covid tests that<03:27:27.439
Summary:
The Finance Division III work session focused on the Department of Health and Human Services’ Division of Public Health Services budget. Department staff said Public Health has a relatively small budget compared with other DHHS divisions, is supported mostly by federal and other non-General funds, and contains nearly 100 accounting units and more than 50 federal grants. They emphasized that the governor’s budget did not include significant cuts, but that federal funding uncertainty and the winding down of pandemic-era resources were major factors affecting the division. The division also explained that some apparent budget growth reflects reorganizations, including moving the Bureau of Emergency Preparedness, Response, and Recovery and some programs from other DHHS divisions into Public Health.
The presentation described Public Health’s mission as serving the entire state through food and water safety, disease surveillance, emergency response, maternal and child health, chronic disease prevention, WIC, community health center support, and public health data collection. Members asked about bird flu, and staff explained that human-health response would involve Public Health’s lab, infectious disease, and emergency preparedness units, while animal-health issues are handled with the Department of Agriculture; they also noted ongoing milk testing requested by FDA and USDA. The division said its organizational structure includes bureaus for Family Health and Nutrition, Infectious Disease Control, Public Health Protection, Emergency Preparedness, Prevention and Wellness, Statistics and Informatics, and Public Health Laboratories, with about a 15% vacancy rate.
Committee members questioned whether the division’s budget and staffing had really grown since pre-COVID, and staff responded that full-time authorized staffing is about the same as in 2018, with the increase largely due to federal pandemic funding that has since receded and to program transfers between divisions. They said Public Health’s General Fund share is about $24 million out of roughly $1.1 billion in DHHS General Fund spending, or about 2.2% of the department total. Members also asked about the 3,000-position cap and unfunded positions; staff explained that the cap remains in chapter law through June 30, 2025, that 394 positions were unfunded in the governor’s budget, and that the division expects flexibility to move money from personnel lines and fill unfunded positions to manage changing needs. No votes or formal actions were taken in this portion of the work session.
AR
Arkansas 2026 Regular Session
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL Jul 9th, 2026
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL
Transcript Highlights:
- It is also the most expensive disease to treat, costing our economy $409 billion.
- It's a very exciting time to work on this disease.
- POINTER tested for us is we tested two cohorts of people. One was in a guided group.
- disease.
- Because as the disease progresses, the needs of the families change.
Summary:
The Arkansas Alzheimer’s Disease and Dementia Advisory Council met with legislative members and agency, advocacy, and provider representatives present. The council adopted its rules and procedures, approved the prior meeting minutes, and authorized the co-chairs to approve special expenses. Members then heard an extensive update on the state Alzheimer’s plan and current developments in diagnosis, treatment, research, caregiving, and workforce issues.
David Cook of the Alzheimer’s Association described major changes since the first state plan, including the growth of blood-based biomarkers, broader access to amyloid PET scans, and the availability of disease-slowing treatments such as Leqembi and Kisunla. He emphasized that Arkansas still faces major barriers in rural areas, including limited provider awareness, insurance coverage concerns, shortages of specialists, and long wait times for memory care and infusion services. He also highlighted caregiver burden, the need for better education and care navigation, and new efforts such as a dementia resource center pilot with UAMS, respite grants, and workforce training. Members discussed the importance of public education on brain health, diet, exercise, and risk reduction, as well as the need to collaborate with chronic disease partners and improve outreach to primary care providers.
The council approved four proposed focus areas for the next state plan: advancing risk reduction, brain health, early detection and diagnosis; strengthening family caregiver support; improving access to diagnostics and treatment; and supporting access and quality of care, including workforce training and crisis response. Members also discussed possible legislative or statutory changes to keep the council active and engaged, and they agreed to pursue a future meeting in August, tentatively August 12 in Hot Springs, with additional meetings under consideration for later in the month. The meeting adjourned after no further business.
AR
Arkansas 2026 1st Special Session
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL Jul 9th, 2026
ALZHEIMER'S DISEASE AND DEMENTIA ADVISORY COUNCIL
MN
Minnesota 2025-2026 Regular Session
Press Conference: New Bill Adds Metachromatic Leukodystrophy to Newborn Screening List - 2/20/25
Transcript Highlights:
- diagnosis genetic testing was done on diagnosis genetic testing was done on our<00:06:34.280>
entire - <00:14:20.480>
positive and 11 girls have been tested positive and 11 girls have been tested - founded Khloe's fight RAR disease founded Khloe's fight RAR disease Foundation<00:27:28.279>
- Doctors knew to test for it in the younger child because MLD is a genetic disease.
- So I have a question for you as well. um we add a rare disease to the newborn um we add a rare disease
MN
Minnesota 2025-2026 Regular Session
Committee on Agriculture, Veterans, Broadband and Rural Development - 01/22/25
Agriculture, Veterans, Broadband, and Rural Development
Transcript Highlights:
- testing program and to me they tested testing program and to me they tested out<00:40:28.400>
- It is an upper respiratory disease. It's a reproductive disease.
- <01:20:29.080>
it disease it's a reproductive disease it disease it's a reproductive disease - They are conducting tests to determine if there's any risk of those vaccines spreading disease amongst
- They are conducting tests to determine if there's any risk of those vaccines spreading disease amongst
CA
California 2025-2026 Regular Session
Assembly Budget Subcommittee No. 1 on Health Apr 21st, 2025
Transcript Highlights:
- It protects us from disease. It's valuable to our communities. It protects us from disease.
- So sometimes when you give disease-specific funding, it's disease A, and you can only use it for disease
- So sometimes when you give disease specific funding, it's disease A, and you can only use it for disease
- Disease goes anywhere.
- I mean, we all remember in 2020 when we could not test enough to know how much disease was circulating
Summary:
The subcommittee held an oversight hearing on federal actions affecting California’s public health and family planning systems, focusing first on the freeze to Title X family planning funds and then on broader CDC/public health grant terminations. Chair and members described the cuts as abrupt, harmful, and likely to create major gaps in disease surveillance, vaccination, contraception, STI testing, and other preventive services, while also criticizing the federal administration’s explanation that the actions were tied to DEI or civil-rights compliance. The chair thanked Attorney General Bonta for legal action and said the hearing was intended to document the real-world impacts and inform state budget responses.
Witnesses from Essential Access Health, Planned Parenthood Affiliates of California, a Central Coast clinic, and other providers said California’s Title X network serves more than half a million low-income patients annually and relies on the funds for staffing, outreach, training, mobile and school-based clinics, and confidential care. They warned that the freeze has already forced reserve spending, delayed services, and could lead to layoffs, reduced hours, longer waits, and fewer appointments, especially for sexual and reproductive health care. Public comment included support for a proposed state backfill of Title X losses, with advocates emphasizing impacts on low-income, LGBTQ+, and communities of color.
On the public health side, CDPH, county health officials, and local health officers testified that the CDC’s rescission of $11.4 billion in grants would affect California by an estimated $840 million and threaten lab capacity, immunization programs, health disparities work, and data systems such as CalConnect and vaccine registries. Sacramento County and others described how the grants supported outbreak response, sequencing, community vaccination clinics, and equity-focused partnerships, and said terminations had already led to canceled appointments, stopped contracts, and layoffs. Several speakers urged the Legislature to preserve and expand state “future of public health” funding and to backfill federal losses, while public commenters from HIV, immunization, labor, and county organizations echoed concerns about workforce losses and worsening health outcomes.
CA
California 2025-2026 Regular Session
Assembly Budget Subcommittee No. 1 on Health Apr 21st, 2025
Transcript Highlights:
- . vector-borne diseases.
- Disease goes anywhere.
- Disease investigators were able to quickly contact trace to investigate the disease, find the source,
- Disease investigators were able to quickly contact trace to investigate the disease, find the source,
- specialists, and Hep C point-of-care test machines.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Financial Services Jun 21st, 2026 at 10:00 am
Joint Committee on Financial Services
Transcript Highlights:
- And lastly, there are so many different chronic diseases, diabetes, hypertension, heart disease, where
- Kilcoin, rare diseases, Alzheimer's, lots of other diseases, and this is the future of treating those
- Ensuring equitable access to biomarker testing by improving coverage for and access to testing across
- Ensuring equitable access to biomarker testing by improving coverage for and access to testing across
- , complex, and expensive disease.
Summary:
The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health.
Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.
TX
Transcript Highlights:
- It's a terrible disease. All of these diseases are terrible.
- Oh yes, that's a huge issue in all diseases, but especially for dementia disease.
- We have earlier diagnoses for some of these dementia diseases. you know, blood tests, we have some clinical
- Blood tests? Blood tests. Do you ever use DNA tests? Determine metabolic pathways?
- So, yes, do I get testing?